Robotics Bottleneck Research机器人瓶颈研究

Main主页 / companies / public / estun

company

ESTUN埃斯顿 002747

Country国家 China中国

Systems系统 Work工作 · Integration集成 · Muscle肌肉 · Nerves神经

Bottlenecks瓶颈 P05 Middleware & orchestration中间件与编排 · P14 Actuators, reducers, encoders执行器、减速器与编码器 · P17 Integration, uptime, service集成、在线率与服务 · P18 Vertical workflow ROI垂直工作流 ROI

Market cap市值 Live, via TradingView.实时数据,来自 TradingView。

Servo, motion control, industrial robots and workcells, vertically integrated across body and components.

伺服、运动控制、工业机器人与工作站;本体与零部件垂直整合。

What it doesServo, motion control, industrial robots and workcells, vertically integrated across body and components.

在干什么伺服、运动控制、工业机器人与工作站;本体与零部件垂直整合。

Name sheetESTUN Automation

Why it mattersThe Chinese test case for whether supplying your own components can rescue whole-machine gross margin.

为何重要检验“零部件自供能否挽回本体毛利率”这一命题的中国样本。

Caveat

Recast before quoting any profit figure. The H1 2026 preannouncement of 2026-07-15 puts attributable net profit at RMB 150–180m, up 2,144.74% to 2,593.68% year over year, but recurring net profit at only RMB 60–75m.

In Q1 2026 attributable net profit was RMB 97.84m (+674.64%) with non-recurring items of RMB 86.54m and recurring net profit of RMB 19.36m, reported as more than 88% of Q1 net profit coming from non-sustainable items; note that 19.36 plus 86.54 does not equal the stated 97.84, most likely a gross-versus-net-of-tax presentation: resolve it from the quarterly report rather than interpolating. Q1 2026 revenue was RMB 1.217bn, down 2.22% year over year: revenue is declining.

FY2025 revenue was RMB 4.888bn (+21.93%) with attributable net profit of RMB 44.97m, recurring net profit of RMB 7.28m and a net margin of 0.93%. The company is pursuing a Hong Kong listing.

Goodwill original cost of RMB 1.34bn is still unverified. Return −22.09%.

风险提示

引用任何利润数字之前,先做重构。2026-07-15 的半年度预告:归母净利 1.5–1.8 亿元,同比 +2,144.74% 至 +2,593.68%,但扣非净利润仅 6,000 万–7,500 万元。

2026 年 Q1 归母净利 9,784 万元(+674.64%),非经常性损益 8,654 万元,扣非净利润 1,936 万元,有报道称“Q1 净利中超过 88% 来自不可持续项目”;注意 1,936 + 8,654 ≠ 9,784,很可能是税前与税后列示口径的差异,应从季报中查实,不得插值估算。2026 年 Q1 收入 12.17 亿元,同比 −2.22%:收入在下滑。

FY2025 收入 48.88 亿元(+21.93%),归母净利 4,497 万元,扣非净利润 728 万元,净利率 0.93%。公司正在推进香港上市。

13.4 亿元商誉原值仍未验证。回报 −22.09%。

ProductServo, motion control, industrial robots, and workcells

Value accrualLocal cost, channel, component integration, and application delivery

Key riskFY2025 revenue RMB4.89bn but net income RMB45m; goodwill gross balance RMB1.34bn. H1 2026 profit growth included asset-swap fair-value income. Recast recurring profit and test debt, goodwill, and cash conversion.

Bottlenecks瓶颈 P05 Middleware & orchestration中间件与编排 · P14 Actuators, reducers, encoders执行器、减速器与编码器 · P17 Integration, uptime, service集成、在线率与服务 · P18 Vertical workflow ROI垂直工作流 ROI

Class
public
Country
CN
HQ
Nanjing, China
Layer
Actuation / Robot OEM / Integrator
Systems
work · body · muscle · nerves
Caveat stance
avoid
Ticker
002747
Exchange
SZSE
Purity
High
Valuation tier
2
Last verified
2026-08-12
Confidence note
High
Sources
S-PUB-018
Translated fields
what_it_does_en · why_it_matters_en · caveat_en
Chain position
midstream
COMPANY RESEARCH公司研究 Commercial evidence商业证据 Expand +展开 + Collapse −收起 −
Commercial evidence shows how far a company has moved from a product claim to repeatable customer value. We look for a defined customer task, paid deployment, operating results, the human help required, and economics that can support repeat use. Missing information stays unassessed; it does not count as evidence against the company.商业证据用于判断一家公司从产品宣称走到了可重复客户价值的哪一步。我们关注明确的客户任务、付费部署、运行结果、所需人工协助,以及能否支持重复采用的经济性。缺失信息保持未评估,不会被当作对公司的负面证据。 Each item below applies only to the cited document and period. It should be read with its evidence class, review date, and stated limits.以下每项内容仅适用于所引文件与期间,阅读时应同时考虑证据类别、核查日期与已说明的局限。
Customer and task
客户与任务
Not yet assessed in this structured record.本结构化记录尚未评估。
Deployment and payment
部署与付款
Not yet assessed in this structured record.本结构化记录尚未评估。
Task results and human assistance
任务结果与人工协助
Not yet assessed in this structured record.本结构化记录尚未评估。
Cost and repeat purchases
成本与复购
Not yet assessed in this structured record.本结构化记录尚未评估。
What the evidence cannot establish
证据的局限
Not yet assessed in this structured record.本结构化记录尚未评估。
How to evaluate commercial evidence如何评估商业证据